Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden · Delayed Price · Currency is SEK 480.80
+1.80 (0.38%)
Jul 6, 2026, 2:50 PM CET
STO:SOBI Revenue
Swedish Orphan Biovitrum AB had revenue of 7.18B SEK in the quarter ending March 31, 2026, with 11.12% growth. This brings the company's revenue in the last twelve months to 28.96B, up 10.37% year-over-year. In the year 2025, Swedish Orphan Biovitrum AB had annual revenue of 28.24B with 8.50% growth.
Revenue (ttm)
28.96B
Revenue Growth
+10.37%
P/S Ratio
5.72
Revenue / Employee
14.71M
Employees
1,969
Market Cap
165.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.24B | 2.21B | 8.50% |
| Dec 31, 2024 | 26.03B | 3.90B | 17.65% |
| Dec 31, 2023 | 22.12B | 3.33B | 17.74% |
| Dec 31, 2022 | 18.79B | 3.26B | 21.00% |
| Dec 31, 2021 | 15.53B | 268.00M | 1.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioGaia AB | 1.54B |
| EQL Pharma AB | 432.66M |
| Cinclus Pharma Holding AB | 67.51M |
| Cereno Scientific AB | 66.82M |
| Nanexa AB | 54.41M |
| Enzymatica AB | 53.06M |
| Orexo AB | 17.80M |
| Moberg Pharma AB | 14.59M |
Swedish Orphan Biovitrum AB News
- 3 days ago - Swedish Orphan price target raised to SEK 530 from SEK 470 at Barclays - TheFly
- 6 days ago - Swedish Orphan Biovitrum downgraded to Hold from Buy at Pareto - TheFly
- 2 months ago - Swedish Orphan Biovitrum initiated with a Buy at H.C. Wainwright - TheFly
- 2 months ago - Swedish Orphan Biovitrum AB Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Swedish Orphan Biovitrum AB Quarterly report: Q1 2026 - Filings
- 2 months ago - Swedish Orphan Biovitrum AB Slides: Q1 2026 - Filings
- 3 months ago - Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 4 months ago - Swedish Orphan Biovitrum AB Slides: Investor presentation - Filings